Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Compared to Estimates, United Therapeutics (UTHR) Q4 Earnings: A Look at Key Metrics
01:30pm, Wednesday, 25'th Feb 2026
The headline numbers for United Therapeutics (UTHR) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall
United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates
01:20pm, Wednesday, 25'th Feb 2026
United Therapeutics (UTHR) came out with quarterly earnings of $7.7 per share, beating the Zacks Consensus Estimate of $6.78 per share. This compares to earnings of $6.19 per share a year ago.
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript
12:07pm, Wednesday, 25'th Feb 2026
United Therapeutics Corporation (UTHR) Q4 2025 Earnings Call Transcript
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
06:30am, Wednesday, 25'th Feb 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter
United Therapeutics Corporation $UTHR Shares Sold by Chase Investment Counsel Corp
04:51am, Tuesday, 24'th Feb 2026
Chase Investment Counsel Corp reduced its holdings in shares of United Therapeutics Corporation (NASDAQ: UTHR) by 23.8% during the undefined quarter, according to its most recent filing with the Secur
Bernard Horn's Strategic Moves: Exiting The Carlyle Group Inc with a -1.68% Impact
04:01pm, Monday, 23'rd Feb 2026
Exploring the Investment Decisions of a Seasoned Guru Bernard Horn (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2025, pro
USNA or UTHR: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 23'rd Feb 2026
Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and United Therapeutics (UTHR). But which of these two stocks is more attractive to value investors
United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference
07:00am, Monday, 23'rd Feb 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating Officer, will p
Paul Mahon Sells 8,300 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:29am, Saturday, 21'st Feb 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the business's stock in a transaction dated Thursday, February 19th. The shares were sold at an ave
Unveiling United Therapeutics (UTHR) Q4 Outlook: Wall Street Estimates for Key Metrics
10:15am, Friday, 20'th Feb 2026
Get a deeper insight into the potential performance of United Therapeutics (UTHR) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the esti
Shell Asset Management Co. Decreases Position in United Therapeutics Corporation $UTHR
04:21am, Thursday, 19'th Feb 2026
Shell Asset Management Co. cut its holdings in United Therapeutics Corporation (NASDAQ: UTHR) by 83.0% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Ex
Market Today: Moderna rebounds; oil and gold jump
05:34pm, Wednesday, 18'th Feb 2026
Guru Stock PicksLouis Moore Bacon has made the following transactions:Reduce in XLF by 69.62%Sold out in CEGAdd in CLS by 386.7%New position in CLJoel Greenblat
United Therapeutics (UTHR) Expected to Announce Quarterly Earnings on Wednesday
04:12am, Wednesday, 18'th Feb 2026
United Therapeutics (NASDAQ: UTHR - Get Free Report) is anticipated to issue its Q4 2025 results before the market opens on Wednesday, February 25th. Analysts expect the company to announce earnings o
Envestnet Asset Management Inc. Sells 15,252 Shares of United Therapeutics Corporation $UTHR
03:33am, Saturday, 14'th Feb 2026
Envestnet Asset Management Inc. cut its position in United Therapeutics Corporation (NASDAQ: UTHR) by 20.9% in the third quarter, according to the company in its most recent disclosure with the Securi
Renaissance Technologies' Strategic Moves: NVIDIA Corp Sees Significant Reduction
05:04pm, Thursday, 12'th Feb 2026
Exploring the Latest 13F Filing and Investment Shifts Renaissance Technologies (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of
